Indaptus Therapeutics, Inc. (INDP)

Import this data to Google Sheets with:

=jivedata("INDP","financials")

Full statements spill as a table. For one cell: =jivedata("INDP","Revenue") or =jivedata("INDP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Indaptus Therapeutics, Inc.

INDP • CIK 0001857044

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense	$7,621.707	$7,251.097	$9,340.959	$5,217.266
General and Administrative Expense	$8,756.767	$8,114.654	$10,492.554	$9,555.379
Operating Income (Loss)	$-16,378.474	$-15,365.751	$-19,833.513	$-14,772.645
Operating Expenses	$16,378.474	$15,365.751	$19,833.513	$14,772.645
Other Nonoperating Income	—	—	$138.018	$125.017
Net Income (Loss) Attributable to Parent	$-15,423.471	$-15,022.027	$-20,848.916	$-15,423.5
Weighted Average Number of Shares Outstanding, Basic	8,401,047	9,355,710	966,124	64,538,771

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$13,362.053	$5,786.753	$8,507.628	$7,553.82
Prepaid Expense and Other Assets, Current	$633.156	$831.577	$802.54	$434.136
Assets, Current	$13,995.209	$6,618.33	$9,310.168	$2,180.856
Assets	$14,923.878	$7,338.756	$9,310.168	$11,987.956
Operating Lease, Right-of-Use Asset	$173.206	$82.175	$82.175	$8.487
Other Assets, Noncurrent	$754.728	$638.251	$638.251	$392.572
Assets, Noncurrent	$928.669	$720.426	$720.426	$401.059
Accounts Payable and Other Accrued Liabilities, Current	$2,672.327	$3,309.717	$6,158.575	$615.426
Operating Lease, Liability, Current	$101.705	$84.164	$84.164	$8.686
Liabilities, Current	$2,774.032	$3,393.881	$6,158.575	$932.999
Common Stock, Value, Issued	$84.011	$120.139	$21.674	$1,332.424
Preferred Stock, Value, Issued	—	—	$10	$10
Additional Paid in Capital	$57,409.643	$64,263.919	$84,408.018	$95,664.138
Retained Earnings (Accumulated Deficit)	$-45,417.156	$-60,439.183	$-81,288.099	$-85,624.032
Stockholders' Equity Attributable to Parent	$12,076.498	$3,944.875	$3,151.593	$11,372.53
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	1,000,000,000
Common Stock, Shares, Issued	8,401,047	12,013,901	2,167,324	133,242,324
Preferred Stock, Shares Authorized	—	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	—	0	1,000,000	0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-15,423.471	$-15,022.027	$-20,848.916	$-15,423.5
Net Cash Provided by (Used in) Operating Activities	$-13,405.315	$-12,323.188	$-14,823.256	$-14,695.567
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$3,735.253	$-7,575.3	$2,720.875	$1,396.119
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$13,362.053	$5,786.753	$8,507.628	$6,114.242
Depreciation	$1.284	$0.735	$0.735	$0.735
Proceeds from Notes Payable	—	—	$5,714.8	$5,714.8
Share-based Payment Arrangement, Noncash Expense	$2,965.938	$2,305.849	$1,358.082	$1,099.325
Proceeds from Issuance of Common Stock	—	$5,510.591	$6,396.888	$14,339.169
Proceeds from Issuance of Preferred Stock and Preference Stock	—	—	$6,000	$6,000
Proceeds from Warrant Exercises	—	—	$1.908	$1.908
Payment of Financing and Stock Issuance Costs	—	$762.703	$569.465	$249.391
Net Cash Provided by (Used in) Financing Activities	—	$4,747.888	$17,544.131	$20,091.686
Increase (Decrease) in Prepaid Expense and Other Assets	$-161.8	$81.944	$-667.288	$-213.793
Increase (Decrease) in Other Current Liabilities	—	—	$2,848.858	$-1,360.261

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("INDP","financials")

Full statements spill as a table. For one cell: =jivedata("INDP","Revenue") or =jivedata("INDP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.